Chengdu Coen Biotechnology Co., Ltd. announced that it has entered into share transfer and capital increase agreement for CNY 48,750,000 on March 1, 2021. The transaction will include participation from new investors including Hangzhou Taige Equity Investment Partnership Enterprise (LP) investing CNY 7,500,000 into the registered capital of the company for 10% stake and Chengdu Kanghua Biological Products Co., Ltd. (SZSE:300841) investing CNY 41,250,000 of which CNY 7,500,000 will go to registered capital for 10% stake and remaining CNY 33,750,000 will go to capital reserve. The transaction does not need the approvals of Chengdu Kanghua Biological Products Co., Ltd. (SZSE:300841)’s directorate and shareholders.